. 2023 May 31:37:100803.

doi: 10.1016/j.lanwpc.2023.100803. eCollection 2023 Aug.

Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort

Nicholas W S Chew^{1

2}, Bryan Chong¹, Si Min Kuo³, Jayanth Jayabaskaran¹, Mingshi Cai³, Huili Zheng⁴, Rachel Goh¹, Gwyneth Kong¹, Yip Han Chin¹, Syed Saqib Imran⁴, Michael Liang⁴, Patrick Lim⁴, Thon Hon Yong⁵, Boon Wah Liew⁵, Pow Li Chia⁶, Hee Hwa Ho⁶, David Foo⁶, Deanna Khoo⁶, Zijuan Huang⁷, Terrance Chua⁷, Jack Wei Chieh Tan⁷, Khung Keong Yeo⁷, Derek Hausenloy^{1

8

9

10}, Hui Wen Sim^{2

11}, Jieli Kua^{2

11}, Koo Hui Chan^{1

2}, Poay Huan Loh^{1

2

11}, Toon Wei Lim^{1

2}, Adrian F Low^{1

2}, Ping Chai^{1

2}, Chi Hang Lee^{1

2}, Tiong Cheng Yeo^{1

2}, James Yip^{1

2}, Huay Cheem Tan^{1

2}, Mamas A Mamas^{12

13}, Stephen J Nicholls^{14

15}, Mark Y Chan^{1

2}

Affiliations

¹ Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
² Department of Cardiology, National University Heart Centre, National University Health System, Singapore.
³ Policy, Research and Surveillance Division, Health Promotion Board, Singapore.
⁴ Khoo Teck Puat Hospital, Singapore.
⁵ Changi General Hospital, Singapore.
⁶ Tan Tock Seng Hospital, Singapore.
⁷ Department of Cardiology, National Heart Centre, Singapore.
⁸ Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
⁹ National Heart Research Institute Singapore, National Heart Centre, Singapore.
¹⁰ The Hatter Cardiovascular Institute, University College London, London, UK.
¹¹ Department of Cardiology, Ng Teng Fong General Hospital, Singapore.
¹² Institute of Population Health, University of Manchester, Manchester, UK.
¹³ Keele Cardiac Research Group, Centre for Prognosis Research, Keele University, Stoke-on-Trent, UK.
¹⁴ Victorian Heart Institute, Melbourne, Australia.
¹⁵ Monash Heart, Monash Health, Melbourne, Australia.

PMID: 37693863
PMCID: PMC10485675
DOI: 10.1016/j.lanwpc.2023.100803

Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort

Nicholas W S Chew et al. Lancet Reg Health West Pac. 2023.

. 2023 May 31:37:100803.

doi: 10.1016/j.lanwpc.2023.100803. eCollection 2023 Aug.

Authors

Affiliations

¹ Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
² Department of Cardiology, National University Heart Centre, National University Health System, Singapore.
³ Policy, Research and Surveillance Division, Health Promotion Board, Singapore.
⁴ Khoo Teck Puat Hospital, Singapore.
⁵ Changi General Hospital, Singapore.
⁶ Tan Tock Seng Hospital, Singapore.
⁷ Department of Cardiology, National Heart Centre, Singapore.
⁸ Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
⁹ National Heart Research Institute Singapore, National Heart Centre, Singapore.
¹⁰ The Hatter Cardiovascular Institute, University College London, London, UK.
¹¹ Department of Cardiology, Ng Teng Fong General Hospital, Singapore.
¹² Institute of Population Health, University of Manchester, Manchester, UK.
¹³ Keele Cardiac Research Group, Centre for Prognosis Research, Keele University, Stoke-on-Trent, UK.
¹⁴ Victorian Heart Institute, Melbourne, Australia.
¹⁵ Monash Heart, Monash Health, Melbourne, Australia.

PMID: 37693863
PMCID: PMC10485675
DOI: 10.1016/j.lanwpc.2023.100803

Abstract

Background: Understanding the trajectories of metabolic risk factors for acute myocardial infarction (AMI) is necessary for healthcare policymaking. We estimated future projections of the incidence of metabolic diseases in a multi-ethnic population with AMI.

Methods: The incidence and mortality contributed by metabolic risk factors in the population with AMI (diabetes mellitus [T2DM], hypertension, hyperlipidemia, overweight/obesity, active/previous smokers) were projected up to year 2050, using linear and Poisson regression models based on the Singapore Myocardial Infarction Registry from 2007 to 2018. Forecast analysis was stratified based on age, sex and ethnicity.

Findings: From 2025 to 2050, the incidence of AMI is predicted to rise by 194.4% from 482 to 1418 per 100,000 population. The largest percentage increase in metabolic risk factors within the population with AMI is projected to be overweight/obesity (880.0% increase), followed by hypertension (248.7% increase), T2DM (215.7% increase), hyperlipidemia (205.0% increase), and active/previous smoking (164.8% increase). The number of AMI-related deaths is expected to increase by 294.7% in individuals with overweight/obesity, while mortality is predicted to decrease by 11.7% in hyperlipidemia, 29.9% in hypertension, 32.7% in T2DM and 49.6% in active/previous smokers, from 2025 to 2050. Compared with Chinese individuals, Indian and Malay individuals bear a disproportionate burden of overweight/obesity incidence and AMI-related mortality.

Interpretation: The incidence of AMI is projected to continue rising in the coming decades. Overweight/obesity will emerge as fastest-growing metabolic risk factor and the leading risk factor for AMI-related mortality.

Funding: This research was supported by the NUHS Seed Fund (NUHSRO/2022/058/RO5+6/Seed-Mar/03) and National Medical Research Council Research Training Fellowship (MOH-001131). The SMIR is a national, ministry-funded registry run by the National Registry of Diseases Office and funded by the Ministry of Health, Singapore.

Keywords: Acute myocardial infarction; Incidence; Metabolic risk factors; Mortality; Public health.

PubMed Disclaimer

Conflict of interest statement

M.Y.C. receives speaker's fees and research grants from Astra Zeneca, Abbott Technologies and Boston Scientific. S.N. has received research grant support from AstraZeneca, Amgen, Anthera, Cerenis, Eli Lilly, Esperion, InfraReDx, LipoScience; The Medicines Company, New Amsterdam Pharma, Novartis, Resverlogix, Roche, and Sanofi-Regeneron; he has received consulting fees from Akcea, Amarin, Anthera, AstraZeneca, Boehringer-Ingelheim, CSL Behring, Eli Lilly, Esperion, Omthera, Merck, Resverlogix, Sanof-Regeneron, Takeda, and Vaxxinity. N.W.S.C. has received research grant support from NUHS Seed Fund and National Medical Research Council Research Training Fellowship.

Figures

**Fig. 1**
Projected incidence of acute myocardial infarction with concomitant metabolic diseases and risk factors in the Singapore population from 2025 to 2050. Incidence is presented per 100,000 population.

**Fig. 2**
Projected mortality associated with acute myocardial infarction and its concomitant metabolic diseases and risk factors in the Singapore population from 2025 to 2050.

**Fig. 3**
Projected incidence of acute myocardial infarction with concomitant metabolic diseases and risk factors in the Singapore population from 2025 to 2050, stratified by sex. Incidence is presented per 100,000 population.

**Fig. 4**
Projected incidence of acute myocardial infarction with concomitant metabolic diseases and risk factors in the Singapore population from 2025 to 2050, stratified by ethnicity. Incidence is presented per 100,000 population.

**Central Illustration**
Trends and predictions of acute myocardial infarction and its associated metabolic risk factors from 2025 to 2050.

See this image and copyright information in PMC

Cited by

Predicted but not destined: considerations for obesity-related cardiovascular risk projection.
Wang TD, Hung CL, Yeh HI. Wang TD, et al. Lancet Reg Health West Pac. 2023 Jun 19;37:100828. doi: 10.1016/j.lanwpc.2023.100828. eCollection 2023 Aug. Lancet Reg Health West Pac. 2023. PMID: 37693872 Free PMC article. No abstract available.
Cohort profile: AI-driven national Platform for CCTA for clinicaL and industriaL applicatiOns (APOLLO).
Baskaran L, Leng S, Dutta U, Teo L, Yew MS, Sia CH, Chew NW, Huang W, Lee HK, Vaughan R, Ngiam KY, Lu Z, Wang X, Tan EWP, Cheng NZY, Tan SY, Chan MY, Zhong L; APOLLO investigators. Baskaran L, et al. BMJ Open. 2024 Dec 2;14(12):e089047. doi: 10.1136/bmjopen-2024-089047. BMJ Open. 2024. PMID: 39622571 Free PMC article.
A sex-disaggregated analysis of the prognostic value of lean type 2 diabetes mellitus in the adult population with acute myocardial infarction.
Kong G, Koh J, Chia J, Neo B, Chen Y, Cao G, Chong B, Muthiah M, Sim HW, Ng G, Koo CY, Khoo CM, Chan MY, Loh PH, Chew NWS. Kong G, et al. Cardiovasc Diabetol. 2025 Feb 7;24(1):59. doi: 10.1186/s12933-024-02552-0. Cardiovasc Diabetol. 2025. PMID: 39920748 Free PMC article.
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma.
Zaman S, Wasfy JH, Kapil V, Ziaeian B, Parsonage WA, Sriswasdi S, Chico TJA, Capodanno D, Colleran R, Sutton NR, Song L, Karam N, Sofat R, Fraccaro C, Chamié D, Alasnag M, Warisawa T, Gonzalo N, Jomaa W, Mehta SR, Cook EES, Sundström J, Nicholls SJ, Shaw LJ, Patel MR, Al-Lamee RK. Zaman S, et al. Lancet. 2025 Apr 12;405(10486):1264-1312. doi: 10.1016/S0140-6736(25)00055-8. Epub 2025 Mar 31. Lancet. 2025. PMID: 40179933 Free PMC article. Review.
Non-invasive scoring systems of liver fibrosis predict prognosis in the cohort with myocardial infarction.
Wong E, Chen Y, Kong G, Chia J, Zhang A, Mehta A, Jayabaskaran J, Chong B, Cao G, Nah B, Chan MY, Muthiah M, Loh PH, Mamas MA, Chew NW. Wong E, et al. Sci Rep. 2025 Jul 21;15(1):26499. doi: 10.1038/s41598-025-12583-6. Sci Rep. 2025. PMID: 40691268 Free PMC article.

See all "Cited by" articles

References

1. Roth G.A., Mensah G.A., Johnson C.O., et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. - PMC - PubMed
1. World Health Organization Cardiovascular diseases 2021. https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1 Available from:
1. Zhao D. Epidemiological features of cardiovascular disease in Asia. JACC Asia. 2021;1(1):1–13. - PMC - PubMed
1. Chong B., Goh R.S.J., Kong G., et al. Comparison of biodegradable and newer generation durable polymer drug-eluting stents with short-term dual antiplatelet therapy: a systematic review and Bayesian network meta-analysis of randomized trials comprising of 43,875 patients. J Thromb Thrombolysis. 2022;53(3):671–682. - PubMed
1. Arnett D.K., Blumenthal R.S., Albert M.A., et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation. 2019;140(11):e596–e646. - PMC - PubMed

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort

Affiliations

Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

Related information

LinkOut - more resources

Full Text Sources